ImmunaPath — Making Personalized Cancer Vaccine Research Navigable
A healthcare education and navigation platform built around a difficult problem: translating a highly technical, fast-moving oncology topic into something patients and families can actually understand and use.
ImmunaPath started from deep research into neoantigen cancer vaccines and turned that work into a clearer public resource, a newsletter for ongoing updates, and a long-term navigation concept.
Clinical trials in personalized cancer vaccines as of 2026.
The product foundation started from domain research, not trend-chasing.
A signup path for updates as the field evolves.
Patients and families cannot easily navigate this emerging area of oncology.
Personalized cancer vaccines are one of the more promising areas in modern oncology, but the information environment is fragmented and difficult to interpret. Trial listings are technical, media coverage is inconsistent, and the path from “this exists” to “could this apply to me?” is not clear for most families.
That creates a real gap. Even when the underlying research is advancing, the people who need the information most often cannot access it in a usable way.
A platform that turns difficult research into something a patient can actually start with.
ImmunaPath packages complex oncology research into a more navigable format: clearer educational framing, practical orientation around how personalized vaccines work, and a newsletter path that keeps people updated as the landscape changes.
The long-term idea is not just content publishing. It is a navigation surface that can help patients and families understand whether a trial path might exist and what questions they should be asking next.
The hard part was translation, not code.
The challenge here was not software execution. It was synthesis: reading the actual research, distilling it honestly, and designing around trust and comprehension for readers who may be in a frightening situation.
Any organization sitting on complex expertise has the same problem. When the material itself is the barrier, the work is turning it into something a person can use without a background in the field.
Some of the most valuable digital work is translation: turning expert complexity into something people can use.
ImmunaPath’s core value is clarity: careful synthesis and careful communication around a technically complex topic. If your organization’s expertise is what makes your website hard to write, that translation is the actual job.
PainOptix
Clinical software for pain management work. Built with careful scope, physician input, and strong boundaries around sensitive information.
PermitBeam
Weekly building permit and violation emails for people who need to watch specific New York City areas.
ShowFloor.ai
Visualization software for flooring contractors. Upload a photo, choose a coating style, and help customers see the finished result before they commit.
Have a complicated subject that needs a real site?
Send what you've got: a draft, a PDF, a competitor you don't like. We'll tell you whether it's a content problem, a structure problem, or a tooling problem before quoting anything.